Kayothera is developing a paradigm-shifting cancer immunotherapy to drive long-lasting cures in incurable cancers.
Active Portfolio Company
https://kayothera.com/
Location: United States, New Jersey, Princeton
Total raised: $13.2M
Investors 3
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
| 19.05.2021 | MassChalle... | masschalle... |
| 19.07.2023 | WRF Capita... | wrfseattle... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.07.2023 | Series A | $5.2M | Accelerato... |
| 18.03.2022 | Series A | $8M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 20.07.2023 | KayoThera Completes $5.2M Series A Extension | SEATTLE, WA, KayoThera, a therapeutics company developing oral, small molecule inhibitors of the r... | vcnewsdail... |
| 18.03.2022 | KayoThera Raises $8M in Series A Financing | KayoThera, a Seattle, WA-based early-stage therapeutics company advancing novel cancer immunotherapi... | finsmes.co... |
| 16.03.2022 | KayoThera Raises $8M in Series A | PRINCETON, NJ, KayoThera, an early-stage therapeutics company, has closed an $8 million Series A r... | vcnewsdail... |
| 17.05.2021 | MassChallenge Switzerland Announces 6th Cohort | May 17, 2021 (Renens, Switzerland) - MassChallenge Switzerland, part of MassChallenge’s global netwo... | masschalle... |
| - | KayoThera | “Kayothera | Curing incurable cancers” | fastfounde... |
| - | KayoThera: Early-Stage Therapeutics Company Secures $5.2 Mil... | KayoThera – an early-stage therapeutics company developing first-in-class, oral, small molecule inhi... | pulse2.com... |